Elana Gazal
Chief Tech/Sci/R&D Officer chez COLLPLANT BIOTECHNOLOGIES LTD.
Fortune : - $ au 31/03/2024
Profil
Elana Gazal is currently the Vice President of Research & Development at CollPlant Biotechnologies Ltd.
Prior to this, she was the Head of Pharmaceutical Research at NeuroDerm Ltd.
from 2017 to 2022.
Dr. Gazal holds a doctorate degree from The Hebrew University of Jerusalem.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Elana Gazal
| Sociétés | Poste | Début |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
Anciens postes connus de Elana Gazal
| Sociétés | Poste | Fin |
|---|---|---|
| NEURODERM LTD | Chief Tech/Sci/R&D Officer | 01/11/2022 |
Formation de Elana Gazal
| The Hebrew University of Jerusalem | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
